A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆(9)-tetrahydrocannabinol (THC) by vaporisation

BACKGROUND: Significant interest has emerged in the therapeutic and interactive effects of different cannabinoids. Cannabidiol (CBD) has been shown to have anxiolytic and antipsychotic effects with high doses administered orally. We report a series of studies conducted to determine the vaporisation...

Descripción completa

Detalles Bibliográficos
Autores principales: Solowij, Nadia, Broyd, Samantha J, van Hell, Hendrika H, Hazekamp, Arno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Technical Advance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274767/
https://www.ncbi.nlm.nih.gov/pubmed/25319497
http://dx.doi.org/10.1186/2050-6511-15-58

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274767/
https://www.ncbi.nlm.nih.gov/pubmed/25319497
http://dx.doi.org/10.1186/2050-6511-15-58

Ejemplares similares